If you can analyze FFPE
you can translate epigenetics
into the clinic

Epigenovo makes it possible to analyze archived FFPE tissue samples with new technology

Beyond cells and fresh tissue

FFPE samples enable new epigenetic insights

Epigenovo AB is developing products and services to decode epigenetic regulation from archived clinical FFPE samples and empower researchers to transform retrospective research into actionable insight for biomarker discovery and patient stratification.

Higher sensitivity & data quality
Unique single cell capabilities
Minimal tissue used
For archival FFPE samples

why this matters

The Challenge

Formalin-fixed paraffin-embedded (FFPE) samples, being the gold standard for archiving clinical tissue samples, represent the most abundant clinical material globally. Yet, it remains largely inaccessible to chromatin profiling due to DNA damage, leaving a wealth of clinical insight unexplored.

our innovation

The Solution

A spin-out from Uppsala University, Sweden and based on years of academic research in cancer genomics and epigenetics, Epigenovo is pioneering epigenetic assays that rescue the damaged DNA in archived tissue and generate high quality nuclei for highly sensitive epigenetic profiling at bulk and single cell level, faster and easier.

What our collaborators say

“Using Epigenovo’s method for chromatin profiling of FFPE samples, we can now study epigenetic changes in old tissue samples that were once thought too damaged to be useful. This makes it possible to look back at rare diseases and learn from samples in existing biobanks, helping us connect past cases to new discoveries.”

Dr. med. Niklas Gebauer

University Hospital Schleswig-Holstein, Germany

Publications

Through proof‑of‑concept and clinical studies, these publications highlight epigenetic analyses at bulk and single‑cell levels in archived FFPE samples.

Contact us

    Rulla till toppen